Диссертация (1145849), страница 25
Текст из файла (страница 25)
– V. 286. – №. 45. – P.39497-39509.168. Leyton L. Thy-1-interacting molecules and cellular signaling in cis and trans//International review of cell and molecular biology. – 2013. – V. 305. – P. 163.145169. Li J., Zhuan-sun Y.X., Wen B., Wu H., Huang F.T., Ghimire H.B., Ran P. X..Human mesenchymal stem cells elevate CD4+CD25+CD127low/-regulatory Tcells of asthmatic patients via heme oxygenase-1 //Iranian Journal of Allergy,Asthma and Immunology. – 2013. – V. 12. – №. 3. – P. 228-235.170. Li Y., Charif N., Mainard D., Bensoussan D., Stoltz J.F., de Isla N. Donor's agedependent proliferation decrease of human bone marrow mesenchymal stemcells is linked to diminished clonogenicity //Bio-medical materials andengineering.
– 2014. – V. 24. – P. 47-52.171. Li-Weber M., Krammer P.H. Regulation of IL4 gene expression by T cells andtherapeutic perspectives //Nature Reviews Immunology. – 2003. – V. 3. – №. 7.– P. 534-543.172. Lim J.H., Kim J.S., Yoon I.H., Shin J.S., Nam H.Y., Yang S.H., Kim S.J., ParkC.G. Immunomodulation of delayed-type hypersensitivity responses bymesenchymal stem cells is associated with bystander T cell apoptosis in thedraining lymph node //The Journal of Immunology. – 2010. – V.
185. – №. 7. –P. 4022-4029.173. Lim J.Y., Park M.J., Im K.I., Kim N., Jeon E.J., Kim E.J., Cho M.L., Cho S.G.Combination cell therapy using mesenchymal stem cells and regulatory T-cellsprovides a synergistic immunomodulatory effect associated with reciprocalregulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-hostdisease model //Cell transplantation.
– 2014. – V. 23. – №. 6. – P. 703-714.174. Ling E.M., Smith T., Nguyen X.D., Pridgeon C., Dallman M., Arbery J., CarrV.A., Robinson D.S. Relation of CD4+ CD25+ regulatory T-cell suppression ofallergen-driven T-cell activation to atopic status and expression of allergicdisease //The Lancet. – 2004. – V. 363. – №. 9409. – P. 608-615.175. Liotta F., Angeli R., Cosmi L., Filì L., Manuelli C., Frosali F., Mazzinghi B.,Maggi L., Pasini A., Lisi V., Santarlasci V., Consoloni L., Angelotti M.L.,Romagnani P., Parronchi P., Krampera M., Maggi E., Romagnani S.,Annunziato F. Toll-Like Receptors 3 and 4 Are Expressed by Human BoneMarrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-CellModulatory Activity by Impairing Notch Signaling //Stem cells.
– 2008. – V.26. – №. 1. – P. 279-289.176. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., GottliebP.A., Kapranov P., Gingeras T.R., Fazekas de St Groth B., Clayberger C., SoperD.M., Ziegler S.F., Bluestone J.A. CD127 expression inversely correlates withFoxP3 and suppressive function of human CD4+ T reg cells //The Journal ofexperimental medicine. – 2006.
– V. 203. – №. 7. – P. 1701-1711.146177. Liu A.Y., Roudier M.P., True L.D., Heterogeneity in primary and metastaticprostate cancer as defined by cell surface CD profile //The American journal ofpathology. – 2004. – V. 165. – №. 5. – P. 1543-1556.178. Liu-Bryan R., Pritzker K., Firestein G.S., Terkeltaub R. TLR2 signaling inchondrocytes drives calcium pyrophosphate dihydrate and monosodium uratecrystal-induced nitric oxide generation //The Journal of Immunology. – 2005. –V.
174. – №. 8. – P. 5016-5023.179. Lombardo E., DelaRosa O., Mancheño-Corvo P., Menta R., Ramírez C.,Büscher D. Toll-like Receptor–Mediated Signaling in Human Adipose-DerivedStem Cells: Implications for Immunogenicity and Immunosuppressive Potential//Tissue Engineering Part A. – 2008. – V. 15. – №. 7.
– P. 1579-1589.180. Luz-Crawford P., Kurte M., Bravo-Alegría J., Contreras R., Nova-Lamperti E.,Tejedor G., Noël D., Jorgensen C., Figueroa F., Djouad F., Carrión F.Mesenchymal stem cells generate a CD4+ CD25+ Foxp3+ regulatory T cellpopulation during the differentiation process of Th1 and Th17 cells //Stem cellresearch & therapy. – 2013. – V.
4. – №. 3. – P. 65.181. Lu X., Liu T., Gu L., Huang C., Zhu H., Meng W., Xi Y., Li S., Liu Y.Immunomodulatory effects of mesenchymal stem cells involved in favoringtype 2 T cell subsets //Transplant immunology. – 2009. – V. 22. – №. 1. – P. 5561.182. Lv F.J., Tuan R.S., Cheung K., Leung V.Y. Concise review: the surfacemarkers and identity of human mesenchymal stem cells //Stem cells. – 2014. –V. 32. – №.
6. – P. 1408-1419.183. Madec A.M., Mallone R., Afonso G., Abou Mrad E., Mesnier A., Eljaafari A.,Thivolet C. Mesenchymal stem cells protect NOD mice from diabetes byinducing regulatory T cells //Diabetologia. – 2009. – V. 52. – №. 7. – P. 13911399.184. Mafi P., Hindocha S., Mafi R., Griffin M., Khan W.S. Suppl 2: AdultMesenchymal Stem Cells and Cell Surface Characterization-A SystematicReview of the Literature //The open orthopaedics journal. – 2011.
– V. 5. – P.253.185. Manicassamy S., Pulendran B. Modulation of adaptive immunity with Toll-likereceptors //Seminars in immunology. – Academic Press, 2009. – V. 21. – №. 4.– P. 185-193.186. Martín P., Gómez M., Lamana A., Cruz-Adalia A., Ramírez-Huesca M., UrsaM.A., Yáñez-Mo M., Sánchez-Madrid F. CD69 association with Jak3/Stat5proteins regulates Th17 cell differentiation //Molecular and cellular biology. –2010. – V.
30. – №. 20. – P. 4877-4889.147187. Mardiney M., Brown M.R., Fleisher T.A. Measurement of T-cell: CD69expression A rapid and efficient means to assess mitogen- or antigen-inducedproliferative capacity in normals//Cytometry. – 1996. – V.26 – P.305-310.188. McClellan J.B., Garner C.W. Purification and properties of human intestinealanine aminopeptidase //Biochimica et Biophysica Acta (BBA)-Enzymology. –1980. – V. 613. – №. 1.
– P. 160-167.189. Meisel R., Zibert A., Laryea M., Göbel U., Däubener W., Dilloo D. Humanbone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation //Blood. – 2004. – V. 103. –№. 12. – P. 4619-4621.190. Melief S.M., Zwaginga J.J., Fibbe W.E., Roelofs H. Adipose tissue-derivedmultipotent stromal cells have a higher immunomodulatory capacity than theirbone marrow-derived counterparts //Stem Cells Transl Med. – 2013. – V. 2. –№. 6. – P. 455-463.191. Meng H.B., Gong J., Zhou B., Hua J., Yao L., Song Z.S.
Therapeutic effect ofhuman umbilical cord-derived mesenchymal stem cells in rat severe acutepancreatitis //International journal of clinical and experimental pathology. –2013. – V. 6. – №. 12. – P. 2703.192. Meylan E., Tschopp J., Karin M. Intracellular pattern recognition receptors inthe host response //Nature. – 2006. – V. 442. – №. 7098. – P. 39-44.193. Mihu C.M., Rus Ciuca D., Soritau O., Susman S., Mihu, D. Isolation andcharacterization of mesenchymal stem cells from the amniotic membrane //RomJ Morphol Embryol.
– 2009. – V. 50. – №. 1. – P. 73-77.194. Mina-Osorio P. The moonlighting enzyme CD13: old and new functions totarget //Trends in molecular medicine. – 2008. – V. 14. – №. 8. – P. 361-371.195. Mitchell J.B., McIntosh K., Zvonic S., Garrett S., Floyd Z.E., Kloster A., DiHalvorsen Y., Storms R.W., Goh B., Kilroy G., Wu X., Gimble J.M.Immunophenotype of Human Adipose-Derived Cells: Temporal Changes inStromal-Associated and Stem Cell–Associated Markers //Stem cells. – 2006. –V.
24. – №. 2. – P. 376-385.196. Musina R.A., Bekchanova E.S., Sukhikh G.T. Comparison of mesenchymalstem cells obtained from different human tissues //Bulletin of experimentalbiology and medicine. – 2005. – V. 139. – №. 4. – P. 504-509.197. Nagatomo K., Komaki M., Sekiya I., Sakaguchi Y., Noguchi K., Oda S.,Muneta T., Ishikawa I. Stem cell properties of human periodontal ligament cells//Journal of periodontal research. – 2006. – V. 41. – №. 4. – P. 303-310.148198. Najar M., Raicevic G., Boufker H.I., Kazan H.F., De Bruyn C., Meuleman N.,Lagneaux L. Mesenchymal stromal cells use PGE2 to modulate activation andproliferation of lymphocyte subsets: Combined comparison of adipose tissue,Wharton’s Jelly and bone marrow sources //Cellular immunology.
– 2010. – V.264. – №. 2. – P. 171-179.199. Nilsson K. Synthesis and secretion of IgE by an established human myelomacell line //Clin. Exp. Immunol. – 1971. – V. 9. – P. 785-793.200. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 andthe interleukin-10 receptor //Annual review of immunology. – 2001. – V. 19. –№. 1. – P.
683-765.201. Nasef A., Chapel A., Mazurier C., Bouchet S., Lopez M., Mathieu N., SensebéL., Zhang Y., Gorin N.C., Thierry D., Fouillard L. Identification of IL-10 andTGF-β Transcripts Involved in the Inhibition of T-Lymphocyte ProliferationDuring Cell Contact With Human Mesenchymal Stem Cells //Gene expression.– 2006. – V. 13. – №. 4-5. – P. 217-226.202. Nassiri F., Cusimano M.D., Scheithauer B.W., Rotondo F., Fazio A., YousefG.M., Syro L.V., Kovacs K., Lloyd R.V.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
